Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsis

被引:13
|
作者
Gander-Bui, Hang Thi Thuy [1 ,2 ]
Schlaurofli, Joeurolle [1 ]
Baumgartner, Johanna [1 ,2 ]
Walthert, Sabrina [1 ]
Genitsch, Vera [3 ]
van Geest, Geert [4 ]
Galvan, Jose A. [3 ]
Cardozo, Carmen [3 ]
Martinez, Cristina Graham [3 ]
Grans, Mona [5 ]
Muth, Sabine [5 ]
Bruggmann, Remy [4 ]
Probst, Hans Christian [5 ]
Gabay, Cem [6 ]
Freigang, Stefan [1 ]
机构
[1] Univ Bern, Inst Tissue Med & Pathol, Div Expt Pathol, CH-3008 Bern, Switzerland
[2] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3012 Bern, Switzerland
[3] Univ Bern, Inst Tissue Med & Pathol, CH-3008 Bern, Switzerland
[4] Univ Bern, Interfac Bioinformat Unit, CH-3012 Bern, Switzerland
[5] Univ Med Ctr Mainz, Inst Immunol, D-55131 Mainz, Germany
[6] Univ Hosp Geneva, Dept Med, Div Rheumatol, CH-1211 Geneva, Switzerland
基金
瑞士国家科学基金会;
关键词
HOST-DEFENSE; NLRP3; INFLAMMASOME; DENDRITIC CELLS; IMMUNITY; INNATE; RECOGNITION; INTERFERONS; HOMEOSTASIS; INFECTIONS; DEFICIENCY;
D O I
10.1016/j.immuni.2023.06.023
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Invasive fungal infections are associated with high mortality rates, and the lack of efficient treatment options emphasizes an urgency to identify underlying disease mechanisms. We report that disseminated Candida albicans infection is facilitated by interleukin-1 receptor antagonist (IL-1Ra) secreted from macrophages in two temporally and spatially distinct waves. Splenic CD169+ macrophages release IL-1Ra into the bloodstream, impeding early neutrophil recruitment. IL-1Ra secreted by monocyte-derived tissue macrophages further impairs pathogen containment. Therapeutic IL-1Ra neutralization restored the functional competence of neutrophils, corrected maladapted hyper-inflammation, and eradicated the otherwise lethal infection. Conversely, augmentation of macrophage-secreted IL-1Ra by type I interferon severely aggravated disease mortality. Our study uncovers how a fundamental immunoregulatory mechanism mediates the high disease susceptibility to invasive candidiasis. Furthermore, interferon-stimulated IL-1Ra secretion may exacerbate fungal dissemination in human patients with secondary candidemia. Macrophage-secreted IL-1Ra should be considered as an additional biomarker and potential therapeutic target in severe systemic candidiasis.
引用
收藏
页码:1743 / +
页数:28
相关论文
共 50 条
  • [21] EXPRESSION AND REGULATION OF HUMAN ALVEOLAR MACROPHAGE DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST
    MOORE, SA
    STRIETER, RM
    ROLFE, MW
    STANDIFORD, TJ
    BURDICK, MD
    KUNKEL, SL
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1992, 6 (06) : 569 - 575
  • [22] ENDOGENOUS INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTECTS AGAINST APOPTOSIS & CARDIAC REMODELING AFTER ACUTE MYOCARDIAL INFARCTION
    Varma, A.
    Salloum, F. N.
    Hoke, N. N.
    Van Tassell, B. W.
    Abbate, A.
    Vetrovec, G. W.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 302 - 302
  • [23] Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity
    Zhu, Jinzhou
    Zhang, Jing
    Xiang, Di
    Zhang, Zhonghui
    Zhang, Lin
    Wu, Mingyuan
    Zhu, Shunying
    Zhang, Ruiyan
    Han, Wei
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 643 (2-3) : 247 - 253
  • [24] Sepsis inhibits synthesis of myofibrillar and sarcoplasmic proteins: Modulation by interleukin-1 receptor antagonist
    Vary, TC
    Owens, EL
    Beers, JK
    Verner, K
    Cooney, RN
    SHOCK, 1996, 6 (01): : 13 - 18
  • [25] Interleukin-1 Receptor Antagonist Decreases Hypothalamic Oxidative Stress During Experimental Sepsis
    Wahab, Fazal
    Santos-Junior, Nilton N.
    de Almeida Rodrigues, Rodrigo Pereira
    Costa, Luis Henrique A.
    Catalo, Carlos Henrique R.
    Rocha, Maria Jose A.
    MOLECULAR NEUROBIOLOGY, 2016, 53 (06) : 3992 - 3998
  • [26] Interleukin-1 Receptor Antagonist Decreases Hypothalamic Oxidative Stress During Experimental Sepsis
    Fazal Wahab
    Nilton N. Santos-Junior
    Rodrigo Pereira de Almeida Rodrigues
    Luis Henrique A. Costa
    Carlos Henrique R. Catalão
    Maria Jose A. Rocha
    Molecular Neurobiology, 2016, 53 : 3992 - 3998
  • [27] Endogenous Interleukin-1 Receptor Antagonist Protects Against Severe Adverse Cardiac Remodeling After Acute Myocardial Infarction
    Salloum, Fadi N.
    Hoke, Nicholas N.
    Varma, Amit
    Van Tassell, Benjamin
    Toldo, Stefano
    Chau, Vinh Q.
    Vecile, Elena
    Dobrina, Aldo
    Abbate, Antonio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A151 - A151
  • [28] AN INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN PROTECTS INSULIN-PRODUCING BETA-CELLS AGAINST SUPPRESSIVE EFFECTS OF INTERLEUKIN-1-BETA
    EIZIRIK, DL
    TRACEY, DE
    BENDTZEN, K
    SANDLER, S
    DIABETOLOGIA, 1991, 34 (06) : 445 - 448
  • [29] A RECOMBINANT HUMAN RECEPTOR ANTAGONIST TO INTERLEUKIN-1 IMPROVES SURVIVAL AFTER LETHAL ENDOTOXEMIA IN MICE
    ALEXANDER, HR
    DOHERTY, GM
    BURESH, CM
    VENZON, DJ
    NORTON, JA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04): : 1029 - 1032
  • [30] Interleukin-1 receptor antagonist (IL-1ra) protects against tissue injury in an animal model of hemorrhagic colitis.
    Bloom, PD
    Russell, R
    Blake, D
    Boedeker, E
    GASTROENTEROLOGY, 1997, 112 (04) : A938 - A938